Risk factors for esophago-jejunal anastomosis leakage after total gastrectomy for cancer. A multicenter retrospective study of the Italian research group for gastric cancer
Reoperation
Adult
Male
Adolescent
Respiratory Tract Diseases
Anastomotic Leak
Comorbidity
Postoperative Hemorrhage
Conservative Treatment
Comorbidities
Comorbidities; Esophago-jejunal anastomosis leakage; Gastric cancer; Minimally invasive surgery; Total gastrectomy
Young Adult
03 medical and health sciences
Postoperative Complications
Esophagus
Ileus
0302 clinical medicine
Minimally invasive surgery
Risk Factors
Stomach Neoplasms
Gastrectomy
Surgical Wound Dehiscence
Minimally Invasive Surgical Procedures
Humans
Endoscopy, Digestive System
Mortality
Retrospective Studies
Aged
Aged, 80 and over
Anastomosis, Surgical
Carcinoma
Middle Aged
Length of Stay
Comorbidities; Esophago-jejunal anastomosis leakage; Gastric cancer; Minimally invasive surgery; Total gastrectomy; Adolescent; Adult; Aged; Aged, 80 and over; Anastomosis, Surgical; Anastomotic Leak; Carcinoma; Comorbidity; Conservative Treatment; Endoscopy, Digestive System; Esophagus; Female; Humans; Ileus; Italy; Jejunum; Length of Stay; Lymph Node Excision; Male; Middle Aged; Minimally Invasive Surgical Procedures; Mortality; Postoperative Complications; Postoperative Hemorrhage; Reoperation; Respiratory Tract Diseases; Retrospective Studies; Risk Factors; Stomach Neoplasms; Surgical Wound Dehiscence; Survival Rate; Young Adult; Gastrectomy
Esophago-jejunal anastomosis leakage
3. Good health
Survival Rate
Jejunum
Italy
Total gastrectomy
Lymph Node Excision
Female
Gastric cancer
DOI:
10.1016/j.ejso.2020.06.035
Publication Date:
2020-07-09T01:13:22Z
AUTHORS (37)
ABSTRACT
Many Eastern reports attempted to identify predictive variables for esophago-jejunal anastomosis leakage (EJAL) after total gastrectomy for cancer. There are no definitive answers about reliable risk factors for EJAL. This retrospective study shows the largest Western series focused on this topic.This is a multicenter retrospective study analyzing patients' datasets collected by 18 Italian referral Centres of the Italian Research Group for Gastric Cancer (GIRCG) from 2000 to 2018. The inclusion criteria were pathological diagnosis of gastric and esophageal (Siewert III) carcinoma requiring total gastrectomy. The primary end point of risk analysis was the occurrence of EJAL; secondary end points were post-operative (30-day) morbidity and mortality, length of stay (LoS), and survival.Data of 1750 patients submitted to total gastrectomy were collected. EJAL developed in 116 (6.6%) patients and represented the 26.3% of all the 441 observed post-operative surgical complications. EJAL diagnosis was followed by a reoperation in 39 (33.6%) patients and by an endoscopic/radiological procedure in 30 cases (25.9%). In 47 patients (40.5%) EJAL was managed with conservative approach. Post-operative LoS and mortality were significantly higher after EJAL occurrence (27 days versus 12 days and 8.6% versus 1.6%, respectively). At risk analysis, comorbidities (particularly, if respiratory), minimally invasive surgery, extended lymphadenectomy, and anastomotic technique resulted significant predictive factors for EJAL. EJAL did not significantly affect survival.These results were consistent with Asian experiences: the frequency of EJAL and its higher rate observed in patients with comorbidities or after minimally invasive approach were confirmed.
SUPPLEMENTAL MATERIAL
Coming soon ....
REFERENCES (33)
CITATIONS (27)
EXTERNAL LINKS
PlumX Metrics
RECOMMENDATIONS
FAIR ASSESSMENT
Coming soon ....
JUPYTER LAB
Coming soon ....